Virtual cognitive rehabilitation program for refugees with traumatic brain injury

Feasibility RCT of an Adapted Cognitive Rehabilitation Program for Refugees and Asylum Seekers With TBI and Cognitive Impairment

Not applicable Interventional Massachusetts General Hospital · NCT06839079

This trial will test whether a trauma-informed, paraprofessional-led virtual program can help English- and Spanish-speaking refugees and asylum seekers (ages 18–65) who have had mild-to-moderate TBI and are experiencing memory or thinking problems.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorMassachusetts General Hospital Academic / other
Locations1 site (Boston, Massachusetts)
Trial IDNCT06839079 on ClinicalTrials.gov

What this trial studies

Researchers at Massachusetts General Hospital have adapted an existing cognitive rehabilitation program to be delivered virtually by trained paraprofessionals and tailored for refugees and asylum seekers. In this pilot randomized trial, 50 participants (25 intervention, 25 wait-list control) will complete baseline, 12-week, and 24-week assessments. One group receives the program immediately and the other group receives it after a 12-week waiting period, allowing comparison of short-term changes and feasibility outcomes. The trial enrolls English- and Spanish-speaking adults with mild-to-moderate TBI and subjective cognitive complaints and focuses on practicality, acceptability, and preliminary changes in cognition and daily functioning.

Who should consider this trial

Good fit: Ideal candidates are refugees or asylum seekers aged 18–65 with mild-to-moderate TBI sustained after age 18, who report cognitive difficulties, speak English or Spanish, can give consent, and can participate in virtual sessions.

Not a fit: People with severe TBI, TBI only from childhood, active psychosis or bipolar disorder, current substance use problems, active suicidal ideation, or recent cognitive rehabilitation are unlikely to benefit or are excluded from this trial.

Why it matters

Potential benefit: If successful, the program could improve thinking, memory, and everyday functioning for refugees with TBI while expanding access through a low-cost, virtual, paraprofessional delivery model.

How similar studies have performed: While cognitive rehabilitation has shown benefit for TBI in other populations, delivering a paraprofessional-led, trauma-informed virtual program specifically for refugees is largely novel and not yet proven.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Identify as an asylum seeker, refugee or have been granted asylum or other form of humanitarian relief.
2. Mild or moderate TBI sustained after the age of 18
3. Age 18-65
4. Subjective cognitive impairment
5. English or Spanish language proficiency
6. Ability to provide verbal informed consent
7. Ability and willingness to answer questionnaires and participation in the Intervention

Exclusion Criteria:

1. Participation in cognitive rehabilitation treatment current or in past 3 months
2. Severe TBI or TBI only sustained under the age of 18
3. Diagnosis of bipolar, psychosis, active substance use, self-reported current active suicidal ideation or plan (Potential participants can be screened again after 30 days in the case of suicidal ideation)

Where this trial is running

Boston, Massachusetts

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions TBICognitive SymptomsTraumatic Brain InjuryCognitionRefugeesAsylum Seekers
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.